RGC REGENERON GENETICS CENTER
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 May 2028: the §8 declaration of use).
Record
- Serial number
- 97182437
- Registration number
- 6724984
- Mark type
- Design + words
- Filed
- 21 Dec 2021
- Published for opposition
- 22 Feb 2022
- Registered
- 24 May 2022
- Next maintenance filing
- §8 declaration of use, due by 24 May 2028 (grace period to 24 Nov 2028)
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 042 — Scientific and technological services: Scientific research in the field of genetics, genetic engineering, genetic sequencing, disease modeling, pharmacogenomics, and precision medicine
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 22 Feb 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Feb 2022 — PUBLISHED FOR OPPOSITION
- 02 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jan 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jan 2022 — EXAMINER'S AMENDMENT ENTERED